It’s time for another edition of the Reading Roundup featuring the top blog posts from February 2017. Start off your weekend by kicking back and catching up on what the pharmaceutical industry was reading in February.
Part one reviews why quality culture important to the pharmaceutical industry? Learn about the process one pharmaceutical company used to find shared traits, behaviors and actions attributable to positive quality culture. Part two covers learning about what is common in pharmaceutical industry leaders related to behavior, actions, and traits that aid in employee engagement, attainment of goals, and overall quality culture.
This article was one of five articles nominated for the Roger F. Sherwood Article of the Year Award. Learn about the best practices and new process validation guidelines and initiatives for biopharmaceutical manufacturing that will improve the betterment of the pharmaceutical industry and patients worldwide.
Meet the pharmaceutical companies who's impressive projects took home the honors of 2017 Facility of the Year Awards Winners.
Get all your questions answered on closed aseptic processing including potential cost savings, advantages and disadvantages and best architectural layout for your facility.
Get these great articles delivered straight to your inbox by subscribing to iSpeak, the Official Information Resource of ISPE.
The following blog post was provided by Peyton Myers, an undergraduate student at Appalachian State University. Myers attended the 2023 ISPE Annual Meeting & Expo in Las Vegas as an ISPE Foundation Professional Development Grant recipient.
The integration of data science in biopharmaceutical manufacturing, emphasizing data quality, tech transfer efficiency, and process optimization, is the heart of this track. Led by industry experts, discussions explore leveraging digital twins, predictive analytics, and continuous improvement initiatives. Additionally, interactive roundtable discussions provide attendees with a dynamic forum...
The pharmaceutical sector stands at a crossroads of immense possibilities. We are witnessing an unprecedented surge in innovation, fueled by a remarkable partnership between industry and regulatory authorities. For example, there are initiatives fostered by the US Food and Drug Administration (US FDA) to promote innovation with programs such as CATT (CBER Advanced Technologies Team) and ETP...
